These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24438876)

  • 1. Double-strand adeno-associated virus-mediated exendin-4 expression in salivary glands is efficient in a diabetic rat model.
    Wang J; Wang F; Xu J; Ding S; Guo Y
    Diabetes Res Clin Pract; 2014 Mar; 103(3):466-73. PubMed ID: 24438876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity/type 2 diabetes.
    Di Pasquale G; Dicembrini I; Raimondi L; Pagano C; Egan JM; Cozzi A; Cinci L; Loreto A; Manni ME; Berretti S; Morelli A; Zheng C; Michael DG; Maggi M; Vettor R; Chiorini JA; Mannucci E; Rotella CM
    PLoS One; 2012; 7(7):e40074. PubMed ID: 22808093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Injection of submandibular gland with recombinant Exendin-4 and adeno-associated virus for the treatment of diabetic rats].
    Wang J; Wen J; Bai D; Guo Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 40(11):1179-85. PubMed ID: 26643419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo expression of HGF/NK1 and GLP-1 From dsAAV vectors enhances pancreatic ß-cell proliferation and improves pathology in the db/db mouse model of diabetes.
    Gaddy DF; Riedel MJ; Pejawar-Gaddy S; Kieffer TJ; Robbins PD
    Diabetes; 2010 Dec; 59(12):3108-16. PubMed ID: 20841608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of exendin-4 analogue in early experimental diabetic retinopathy.
    Zhang Y; Wang Q; Zhang J; Lei X; Xu GT; Ye W
    Graefes Arch Clin Exp Ophthalmol; 2009 May; 247(5):699-706. PubMed ID: 19084986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term, antidiabetogenic effects of GLP-1 gene therapy using a double-stranded, adeno-associated viral vector.
    Choi SH; Lee HC
    Gene Ther; 2011 Feb; 18(2):155-63. PubMed ID: 20720576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
    Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S
    J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats.
    Liu WJ; Jin HY; Lee KA; Xie SH; Baek HS; Park TS
    Br J Pharmacol; 2011 Nov; 164(5):1410-20. PubMed ID: 21323903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
    Jin CH; Chae SY; Son S; Kim TH; Um KA; Youn YS; Lee S; Lee KC
    J Control Release; 2009 Feb; 133(3):172-7. PubMed ID: 18977255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4.
    Chen S; Liu AR; An FM; Yao WB; Gao XD
    Age (Dordr); 2012 Oct; 34(5):1211-24. PubMed ID: 21901364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.
    Ding X; Saxena NK; Lin S; Gupta NA; Anania FA
    Hepatology; 2006 Jan; 43(1):173-81. PubMed ID: 16374859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
    Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
    Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of insulin receptor substrate-2 expression by Fc fusion to exendin-4 overexpressed in E. coli: a potential long-acting glucagon-like peptide-1 mimetic.
    Kim JW; Kim K; Ahn Y; Jeong H; Jeong H; Ryu S; Lee S; Lee C; Chung HS; Jang SH
    BMB Rep; 2010 Feb; 43(2):146-9. PubMed ID: 20193135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
    Himeno T; Kamiya H; Naruse K; Harada N; Ozaki N; Seino Y; Shibata T; Kondo M; Kato J; Okawa T; Fukami A; Hamada Y; Inagaki N; Seino Y; Drucker DJ; Oiso Y; Nakamura J
    Diabetes; 2011 Sep; 60(9):2397-406. PubMed ID: 21810596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-Like Peptide-1 Receptor Activation Does not Affect Re-Endothelialization but Reduces Intimal Hyperplasia via Direct Effects on Smooth Muscle Cells in a Nondiabetic Model of Arterial Injury.
    Eriksson L; Saxelin R; Röhl S; Roy J; Caidahl K; Nyström T; Hedin U; Razuvaev A
    J Vasc Res; 2015; 52(1):41-52. PubMed ID: 25966620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta cell specific probing with fluorescent exendin-4 is progressively reduced in type 2 diabetic mouse models.
    Lehtonen J; Schäffer L; Rasch MG; Hecksher-Sørensen J; Ahnfelt-Rønne J
    Islets; 2015; 7(6):e1137415. PubMed ID: 26963143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term exendin-4 treatment delays natural deterioration of glycaemic control in diabetic Goto-Kakizaki rats.
    Simonsen L; Pilgaard S; Orskov C; Hartmann B; Holst JJ; Deacon CF
    Diabetes Obes Metab; 2009 Sep; 11(9):884-90. PubMed ID: 19508463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
    Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
    J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent effects of GLP-1 analogs exendin-4 and exendin-9 on the expression of myosin heavy chain isoforms in C2C12 myotubes.
    Wang L; Guo F; Wei S; Zhao R
    Peptides; 2011 Jun; 32(6):1313-9. PubMed ID: 21453734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healing.
    Roan JN; Cheng HN; Young CC; Lee CJ; Yeh ML; Luo CY; Tsai YS; Lam CF
    J Surg Res; 2017 Feb; 208():93-103. PubMed ID: 27993221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.